L3Harris's Vampire contract validates the C-UAS chokepoint while the Fundrise Innovation Fund's NAV premium collapse deepens.

L3Harris Technologies (LHX) added 2.1% to $310.45, driven by two converging catalysts: a $106 million Army contract announced June 11 for its Vampire counter-UAS system — which has logged over 350,000 operational hours in European combat since 2023 — and a June 16 report detailing plans for an initial public offering of L3Harris's missile division, which would surface an embedded asset the parent's sum-of-parts has undervalued. The Vampire award lands squarely in the RF-detection and interceptors-effectors chokepoints: it is a deployable, proven C-UAS stack awarded to a single-source incumbent, not a prototype, and it covers both mobile and fixed-site configurations. LHX is now up roughly 25% year over year, the best performing name among the defense primes in the drone-sector basket.

VCX — the Fundrise Innovation Fund, which trades on NYSE — fell another 16.4% to $91.99, extending a now-catastrophic post-IPO slide. VCX listed on March 19, 2026 at what analysts estimated was a roughly 4× premium to its net asset value, with the SpaceX pre-IPO stake as the implied unlisted anchor. SpaceX (SPCX) closed its own IPO last week at $135/share and began trading; the "hidden asset" is now liquid and directly buyable. The NAV premium has no remaining justification, and with the lockup on ~100,000 pre-listing restricted shareholders expiring September 19, 2026, the supply overhang is structural. Drone-vertical exposure via VCX — which held positions in pre-revenue autonomy and battery firms alongside SpaceX — is migrating to single-name positions as the fund discount grinds tighter.

The remainder of the drone complex held within its recent range. Kratos (KTOS -0.4%) and AeroVironment (AVAV -0.3%) were essentially flat ahead of AVAV's FQ4/FY2026 print on June 23 — the first full quarter post-BlueHalo against a record $4.6B backlog — which is now the vertical's dominant near-term catalyst. DroneShield (DRSHF) and Ambarella (AMBA) were quiet in the session, consolidating recent gains tied to the $24.9M JTF-401 C-UAS contract and the AI-inference edge-compute upgrade cycle respectively. MP Materials (MP) drifted modestly, with the IP-theft litigation against USA Rare Earth still unresolved and the Fort Worth magnet plant on track for H2 commercial sales. RTX remained near its 52-week high, underpinned by Stinger interceptor production backlog and air-defense export orders into the NATO eastern flank.

Into the open, LHX's missile-IPO process is the new execution variable: a successful structural separation would let L3Harris redeploy capital toward the electronic-warfare and C-UAS franchises that are the drone vertical's chokepoint anchors. The next hard date is AVAV June 23 earnings; after that, the House floor vote on the FY27 NDAA (H.R. 8800, ~July 15) where amendments classifying drone motors, batteries, and ESCs as critical components would directly size the reshored-parts market that the entire NDAA-compliant-supply chokepoint depends on.